An evaluation of low-cost progression markers in H1V-1 seropositive Zambians

HIV Medicine

Volumn 1, Issue 2, 2000, Pages 125-127

  Hosp, M ^a   Lisse, I M ^b   Quigley, M ^c   Mwinga, A M ^d   Godfrey Faussett, P ^e   Porter, Jdh ^a   Luo, N ^b   Pobee, J ^c   Wachter H ^d   McAdam, K P W J ^e   Fuchs, D ^a  

^a UNIVERSITY TEACHING HOSPITAL   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Africa; Haemoglobin; HIV; Progression marker; Total lymphocyte count

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; HEMOGLOBIN; NEOPTERIN;

ADULT; ARTICLE; BLOOD; DISEASE COURSE; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE COUNT; MALE; PREDICTION AND FORECASTING; ZAMBIA;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HEALTH CARE COSTS; HEMOGLOBINS; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMAN; MALE; NEOPTERIN; PREDICTIVE VALUE OF TESTS; ZAMBIA;

EID: 18044403827     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2000.00016.x     Document Type: Article

References (7)

1. Mwinga AM, Hosp M, Godfrey-Faussett F, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12: 2447-2457.
2. Lisse IM, Whittle H, Aaby P, et al. Labelling of T cell subsets under field conditions in tropical countries. Adaptation of the immunoalkaline phosphatase staining method for blood smears. J Immunol Methods 1990; 129: 49-53.
3. Lisse IM, Boettiger B, Christensen LB, et al. Evaluation of T cell subsets by an immunocytochemical method compared to flow cytometry in fourcountri es. Scant} J Immunol 1997; 45:637-644.
4. Whittle H, Egboga A, Todd J, et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HrV-1 orHIV-2 infection. AIDS 1992; 6: 685-689.
5. Kerlikowske KM, Katz MH, Alien S, et al. Beta-2-microglobulin as a predictor of death in HIV-infected women from Kigali. Rwanda AIDS 1994; 8: 963-969.
6. Hosp M, Elliott AM, Raynes JG, et al. Neopterin, beta-2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Lung 1997; 175: 265-275.
7. Blatt SP, Lucey CR, Butzin CA, et al. Total lymphocyte count as a predictor of absolute CD4 count and CD4 percentage in HIV-infected persons. JAMA 1993; 269: 622-626.